79.94
79.94 (0%)
As of Feb 14, 2025
Lantheus Holdings, Inc. [LNTH]
Source:
Company Overview
Lantheus Holdings, Inc. is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes.
| Country | United States |
| Headquarters | north billerica, massachusetts |
| Phone Number | 978 671-8001 |
| Industry | manufacturing |
| CEO | Brian Markison |
| Website | www.lantheus.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $1,533.9 |
| Operating Profit | $457 |
| Net Income | $312.4 |
| Net Cash | $199.2 |
Profit Ratios
| Gross Margin | $988.3 |
| Operating Margin | 29.8 |
| Profit as % of Revenues | 316.3% |
| Profit as % of Assets | 17.2% |
| Profit as % of Stockholder Equity | 28.7% |
Management Effectiveness
| Return on Equity | 28.7% |
| Return on Assets | 15.8% |
| Turnover Ratio | 84.5% |
| EBITA | $457 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,980.3 |
| Total Liabilities | $892.3 |
| Operating Cash Flow | $544.8 |
| Investing Cash Flow | $-226 |
| Financing Cash Flow | $-118.5 |
